The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Atyr Pharma Inc shares valued at $612,437 were purchased by SCHIMMEL PAUL on Oct 08 ’25. At $0.90 per share, SCHIMMEL PAUL acquired 682,001 shares. The insider’s holdings grew to 1,095,024 shares worth approximately $1.04 million following the completion of this transaction.
Also, SCHIMMEL PAUL purchased 317,999 shares, netting a total of over 299,364 in proceeds. Following the buying of shares at $0.94 each, the insider now holds 1,413,023 shares.
Before that, Gross Jane A had added 3,750 shares to its account. In a trade valued at $15,000, the Director bought Atyr Pharma Inc shares for $4.00 each. Upon closing the transaction, the insider’s holdings increased to 3,750 shares, worth approximately $9262.5.
As published in a research note from RBC Capital Mkts on September 16, 2025, Atyr Pharma Inc [ATYR] has been rated down from an Outperform to a Sector perform and the price target has been revised to $1.50. Analysts at Wells Fargo downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal weight”‘ outlook in a report released in mid September. As of September 15, 2025, Leerink Partners has decreased its “an Outperform” rating to a “Market perform” for ATYR. Earlier on September 15, 2025, H.C. Wainwright downgraded its rating. Their new recommendation was “a Neutral” for ATYR stock which previously was a “a Buy”.
Analyzing ATYR Stock Performance
On last trading session, Atyr Pharma Inc [NASDAQ: ATYR] plunged -4.70% to $0.95. The stock’s lowest price that day was $0.9275, but it reached a high of $1.01 in the same session. During the last five days, there has been a surge of approximately 34.24%. Over the course of the year, Atyr Pharma Inc shares have dropped approximately -49.58%. Shares of the company reached a 52-week high of $7.2904 on 07/28/25 and a 52-week low of $0.6816 on 10/01/25.
Support And Resistance Levels for Atyr Pharma Inc (ATYR)
According to the 24-hour chart, there is a support level at 0.9131, which, if violated, would cause prices to drop to 0.8731. In the upper region, resistance lies at 1.0065. The next price resistance is at 1.0599. RSI (Relative Strength Index) is 28.87 on the 14-day chart, showing oversold technical sentiment.
Is Atyr Pharma Inc subject to short interest?
Stocks of Atyr Pharma Inc saw a sharp rise in short interest on 2025-09-15 jumping by 4.84 million shares to 33.09 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 28.25 million shares. A jump of 14.64% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.74 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.74.
Which companies own the most shares of Atyr Pharma Inc (ATYR)?
In terms of Atyr Pharma Inc share price expectations, FactSet research, analysts set an average price target of 1.25 in the next 12 months, up nearly 25.0% from the previous closing price of $1.0. Analysts anticipate Atyr Pharma Inc stock to reach 17 by 2025, with the lowest price target being 1.
